Yan Leyfman: Discussing Artificial Intelligence in Lymphoma Immunotherapy

Source Domain: oncodaily.com

The future of cancer care will be significantly shaped by scientific discovery and the ability to translate innovation into meaningful impact for patients.
Yan Leyfman participated in Technology Networks’ symposium titled “The Landscape of Cancer Research: Advances in Immuno-Oncology 2026,” where he discussed the role of Artificial Intelligence in Lymphoma Immunotherapy.
The symposium highlighted the transformative potential of integrating human expertise, immunotherapy, data science, and artificial intelligence in cancer treatment.
Leyfman emphasized that ongoing work aims to enhance clinical decision-making, accelerate research, and improve access to precision oncology through AI.
He expressed gratitude to the symposium organizers for bringing together an exceptional group of thought leaders and for fostering an environment that underscores both progress made and future opportunities in cancer research.

You may have missed